Valuation Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq 23:00:00 11/09/2026 +03			5-day change	1st Jan Change
515.44 ^USD	+0.17%		-5.62%	+13.69%

09-11	Vertex Pharmaceuticals Incorporated Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-10-2026 02:10 PM
09-10	Vertex Pharmaceuticals Incorporated Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 04:30 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	130,644	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	13.58%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	126,366	123,104	122,147
Change	-	31.13%	47.8%	4.23%	11.09%	16.55%	-2.58%	-0.78%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	53x	27.9x	23.6x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	8.36x	6.64x	5.38x
PEG	-	0.5x	3.51x	2x	-0x	-1.5x	0.3x	1.3x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.86x	8.99x	7.97x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	9.54x	8.47x	7.45x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	32.7x	19.8x	17.8x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	26.3x	20.5x	17.6x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	70.1x	26.4x	24.1x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	1.43%	3.79%	4.14%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	9.729	18.45	21.85
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,248	14,526	16,400
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	3,864	6,205	6,860
EBIT ¹	4,344	4,793	4,375	695.6	5,263	4,813	6,000	6,928
Net income ¹	2,342	3,322	3,620	-535.6	3,953	2,535	4,831	5,688
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-4,277	-7,540	-8,497
Reference price ²	219.60	288.78	406.89	402.70	453.36	515.44	515.44	515.44
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,461	-	-
Announcement Date	1/26/22 A	2/7/23 A	2/5/24 A	2/10/25 A	2/12/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	52.98x	9.54x	32.7x	-.--%	131B
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	19.84x	6.63x	17.02x	2.26%	363.54B
Weighted average by Cap.	24.26x	7.80x	17.78x	1.98%